Fortress Biotech Inc. (FBIO)
Market Open
11 Sep, 14:01
NASDAQ (CM) NASDAQ (CM) Primary $
2. 59
+0.02
+0.7782%
$
90.02M Market Cap
- P/E Ratio
- Div Yield
44,259 Volume
-5.8 Eps
$ 2.57
Previous Close Investors:
Want to track FBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fortress Biotech Inc. (FBIO) Statistics
Valuation metrics
Market Cap 90.02M
Enterprise value -41.44M
Trailing P/E (ttm) 0.83
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.32
Price/Book (mrq) 0.52
Enterprise Value/Revenue -0.61
Enterprise Value/EBITDA -0.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 168.1K
Average volume (90 days) 697.45K
Price summary
52-Week low 2.18
52-Week high 4.53
Beta -
50-Day moving average 3.06
200-Day moving average 2.85
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 10 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 1.63%
Operating margin -0.43%
Operational effectiveness
Return on assets 0.35%
Return on equity 1.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.16
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 3.96%
Book value per share (mrq) 6.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
